Article
Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.
PloS one - 1 Jan 2017
Abram Michael E, Ram Renee R, Margot Nicolas A, Barnes Tiffany L, White Kirsten L, Callebaut Christian, Miller Michael D
Abstract excerpt
T97A is an HIV-1 integrase polymorphism associated with integrase strand transfer inhibitor (INSTI) resistance. Using pooled data from 16 clinical studies, we investigated the prevalence of T97A (pre-existing and emergent) and its impact on INSTI susceptibility and treatment response in INSTI-naive patients who enrolled on elvitegravir (EVG)- or raltegravir (RAL)-based regimens. Prior to INSTI-based therapy,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
